Lupron depot-PED 11.25 MG 3MOS
Ended Awarded Last action
- Contract number
- SPE2DR26FXQ6J
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,325
Award facts
- Contract value 100% obligated
- $20,324.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $20,324.65 to AmerisourceBergen Drug Corp for Lupron Depot-Ped 11.25 mg, a 3-month supply pharmaceutical product, with a completion date of December 9, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle that runs through December 2026 and enables the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical federal vendor that serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through DLA's Medical Supply Chain. The company's portfolio of federal contract awards demonstrates extensive experience delivering specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains. This delivery order for Lupron Depot-Ped, a leuprolide acetate injection used in pediatric endocrinology, reflects AmerisourceBergen's ongoing role as a primary supplier of specialized pharmaceutical products to the military healthcare enterprise.
Quick answers
Who was awarded contract SPE2DR26FXQ6J?
SPE2DR26FXQ6J was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26FXQ6J worth?
The government has obligated $20,325 on SPE2DR26FXQ6J.
Is contract SPE2DR26FXQ6J an order under another contract?
Yes. SPE2DR26FXQ6J is a delivery order under SPE2DR25D6029, an indefinite delivery contract.
Was contract SPE2DR26FXQ6J competed?
The extent of competition for SPE2DR26FXQ6J was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award